Related Experiment Video
Updated: May 16, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Vattikuti Institute Prostatectomy-Technique in 2012
Khurshid R Ghani1, Quoc-Dien Trinh, Mani Menon
1Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA.
Journal of Endourology
|December 13, 2012
Summary
The Vattikuti Institute Prostatectomy (VIP) program, a pioneer in robot-assisted radical prostatectomy (RARP), has refined its techniques over 12 years and 7000+ cases. These advancements aim to improve outcomes and minimize complications for prostate cancer patients.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- The Vattikuti Institute Prostatectomy (VIP) program is celebrating 12 years as the first global initiative for robot-assisted radical prostatectomy (RARP).
- Over 7000 cases have informed the standardization of RARP, focusing on complication reduction and functional outcome enhancement.
- Continuous refinement of surgical techniques is crucial for optimizing patient results in RARP.
Purpose of the Study:
- To detail the current VIP technique for robot-assisted radical prostatectomy.
- To highlight recent refinements in the VIP procedure.
- To evaluate the potential impact of new technologies like the GelPoint access platform on oncologic outcomes.
Main Methods:
- Detailed description of the current VIP surgical technique.
- Incorporation of specific refinements: Veil of Aphrodite nerve sparing with Harmonic ACE curved shears, high anterior release (super Veil), extended pelvic lymph node dissection.
- Utilizing percutaneous suprapubic tube bladder drainage and barbed suture for urethrovesical anastomosis.
Main Results:
- Standardization of RARP following extensive experience with over 7000 cases.
- Demonstrated minimization of complications and enhancement of functional outcomes.
- Introduction of the GelPoint access platform in 2012 for potential oncologic performance improvement.
Conclusions:
- The VIP program has established a robust and refined technique for RARP.
- Ongoing innovations, including nerve-sparing approaches and new platforms, continue to advance surgical care.
- The GelPoint platform shows promise for enhancing oncologic control, particularly in high-risk prostate cancer patients.
